Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.47 |
| ▸ | CNR1 | P21554 | 15/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | RORA | P35398 | 1/20 | 0.40 |
| ▸ | RORC | P51449 | 1/20 | 0.40 |
| ▸ | RORB | Q92753 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GHSR | Q92847 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16152345 | 0.94 | PGR (0.40) | CNR2CNR1PGRRORARORC | |
| SCHEMBL12132275 | 0.86 | CNR2 (0.41) | CNR2CNR1PGRRORARORC | |
| SCHEMBL26280691 | 0.86 | CNR2 (0.39) | CNR2CNR1PGRRORARORC | |
| SCHEMBL12132336 | 0.85 | CNR2 (0.37) | CNR2CNR1PGRRORARORC | |
| SCHEMBL12132333 | 0.80 | RAB9A (0.40) | PGRRORARORCRORBTP53 | |
| SCHEMBL11976578 | 0.79 | RAB9A (0.41) | PGRRORARORCRORBTP53 | |
| SCHEMBL12014970 | 0.78 | CNR2 (0.59) | CNR2CNR1 | |
| SCHEMBL12132328 | 0.78 | RAB9A (0.40) | PGRRORARORCRORBTP53 | |
| SCHEMBL12132323 | 0.78 | RAB9A (0.40) | CNR1TP53SMN1; SMN2 | |
| SCHEMBL23604787 | 0.76 | ABCG2 (0.47) | PGRRORARORCRORBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120205585-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120205585-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME | HDAC10, EMG1, PRMT1 | CNR2 2203/4885CNR1 915/4885PGR 1264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.